Chronic Pulmonary Hypertension Diagnostic Market is segmented By Drug Class (Endothelin Receptor Antagonists, Phosphodiesterase-5 Inhibitors, Prostacyclin Analogues, Soluble Guanylate Cyclase Stimulators), By Disease Type (Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Hypoxic Pulmonary Hypertension, Pulmonary Venous Hypertension), By Route of Administration (Oral, Injectable, Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.